2025 HCPCS Code Q0249
Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
TAGS: require invasive hospitalized patients pediatric systemic supplemental oxygenation years extracorporeal corticosteroids receiving membrane mechanical| Short Description | Tocilizumab for covid-19 |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | June 24, 2021 |
| HCPCS Action Effective Date | June 24, 2021 |
| HCPCS Pricing Indicator Code | 54 - Vaccinations |
| HCPCS Type Of Service Code | V - Pneumococcal/flu vaccine (eff 01/96), Pneumococcal/flu/hepatitis B vaccine (eff 04/95-12/95), Pneumococcal only before 04/95 |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- Q9003 - Chaplain counsel group
- Q9004 - Va whole health partner serv
- Q9950 - Inj sulf hexa lipid microsph
- Q9951 - Locm >= 400 mg/ml iodine,1ml
- Q9953 - Inj fe-based mr contrast,1ml
- Q9954 - Oral mr contrast, 100 ml
- Q9955 - Inj perflexane lip micros,ml
- Q9956 - Inj octafluoropropane mic,ml
- Q9957 - Inj perflutren lip micros,ml
- Q9958 - Hocm <=149 mg/ml iodine, 1ml
- Q9959 - Hocm 150-199mg/ml iodine,1ml
- Q9960 - Hocm 200-249mg/ml iodine,1ml
- Q9961 - Hocm 250-299mg/ml iodine,1ml
- Q9962 - Hocm 300-349mg/ml iodine,1ml
- Q9963 - Hocm 350-399mg/ml iodine,1ml
- Q9964 - Hocm>= 400mg/ml iodine, 1ml
- Q9965 - Locm 100-199mg/ml iodine,1ml
- Q9966 - Locm 200-299mg/ml iodine,1ml
- Q9967 - Locm 300-399mg/ml iodine,1ml
- Q9968 - Visualization adjunct